These days, Brian has taken on another role as a kidney health ambassador in partnership with Boehringer & Lilly’s to raise awareness for chronic kidney disease. Showbiz Cheat Sheet caught up ...

Kidney Disease: Improving Global Outcomes. CKD evaluation and management. ClinicalKey. Semaglutide. Tuttle KR, Lakshmanan MC, Rayner B, et al. Dulaglutide versus insulin glargine in patients with type ...

Introduction. Chronic kidney disease (CKD) is a relatively common condition that affects up to 16% of the population globally (Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013; ...

Too often, patients with chronic kidney disease get diagnosed too late – if at all. Addressing risk factors early can stave off the disease’s worst effects.

Americans now spend more years living with chronic disease than people in 183 other countries in the World Health Organization — a reality that Robert F. Kennedy Jr. framed as a “national ...

Severe mental illnesses affected 7.3% of patients with chronic kidney disease (CKD), representing a 56% higher prevalence than in the general population. The presence of mental illness was linked ...

Within 100 days, an assessment on the childhood chronic disease crisis will be released. It calls for assessing the "threats posed" by "over-utilization of medication, certain food ingredients ...

Let’s dive in with our experts’ cheat sheet as a springboard to decoding your skin’s messages when it comes to some of the most common skin conditions. Acne “Acne can be due to a genetic ...

References: FDA approves Ozempic ® (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney ...

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease.

Novo Nordisk’s type 2 diabetes drug Ozempic has expanded its label to include chronic kidney disease. The new FDA approval comes as makers of GLP-1 drugs work to expand the uses of these products.